Development of a novel FePt-based multifunctional ferroptosis agent for high-efficiency anticancer therapy

Area of Science:

• Nanotechnology
• Biomedical Engineering
• Oncology

Background:

• Ferroptosis is an emerging cell death mechanism with significant potential for cancer therapy.
• Iron-platinum (FePt) nanomaterials offer dual capabilities for imaging and cancer treatment.
• Targeted delivery of therapeutic agents to cancer cells is crucial for effective treatment.

Purpose of the Study:

• To design and synthesize a novel multifunctional nanoparticle (FPEF) for cancer therapy.
• To investigate the ferroptosis-inducing capability of FePt nanoparticles.
• To evaluate the in vitro and in vivo anticancer efficacy of FPEF.

Main Methods:

• Rational design and synthesis of FePt nanoparticles incorporating luminescent lanthanide complexes (PTTA-Eu3+) and folic acid (FA).
• In vitro cytotoxicity assays on FA-positive cancer cell lines (4T1, MCF-7, HeLa).
• In vivo studies in tumor-bearing mice to assess tumor inhibition and therapeutic effects.

Main Results:

• The synthesized FPEF nanoparticles effectively induced cancer cell death through the ferroptosis mechanism.
• In vitro studies showed significant anticancer effects against FA-positive tumor cells.
• In vivo studies demonstrated substantial inhibition of tumor progression in mice.

Conclusions:

• FPEF represents a novel ferroptosis agent with potential for cancer treatment.
• This study provides the first evidence of ferroptosis induction by FePt nanoparticles.
• The multifunctional FPEF nanoparticles show promise for integrated cancer diagnosis and therapy.